单指数、双指数与拉伸指数扩散加权磁共振成像模型鉴别肝血管瘤与肝转移瘤的比较
这项前瞻性研究纳入37例患者共64个肝脏局灶性病变,比较单指数、双指数与拉伸指数DWI模型鉴别肝血管瘤与肝转移瘤的诊断价值。肝转移瘤的ADC、D、f、DDC值显著低于肝血管瘤,α值显著高于肝血管瘤;ADC与DDC的AUC显著高于D*、f与α。作者认为单指数模型的ADC与拉伸指数模型的DDC可作为鉴别两者的定量影像生物标志物。
要点
- 肝转移瘤ADC、D、f、DDC值显著低于肝血管瘤,α值显著高于肝血管瘤。
- ADC与DDC鉴别肝血管瘤与肝转移瘤的AUC分别为0.940与0.952,显著高于D*、f与α。
- ADC与DDC可作为鉴别肝血管瘤与肝转移瘤的定量影像生物标志物。
核心结论
- 单指数模型的ADC与拉伸指数模型的DDC可作为鉴别肝血管瘤与肝转移瘤的定量影像生物标志物。
研究设计与样本
- 前瞻性研究,经本院机构审查委员会批准并取得全部患者书面知情同意;244例已知或疑似肝病患者接受MRI检查,其中37例具有最大直径≥10 mm的肝脏局灶性病变者纳入评估;由两名放射科医生使用自制软件测量三种DWI模型参数;以病理或临床诊断作为参考标准(原文未明确写出参考标准名称)。
关键影像表现/征象
- 共评估64个肝脏局灶性病变,其中22个为肝血管瘤,42个为肝转移瘤。
- 肝转移瘤ADC、D、f、DDC值显著低于肝血管瘤(P分别<0.0001、<0.0001、0.015、<0.0001)。
- 肝转移瘤α值显著高于肝血管瘤(P=0.028)。
诊断标准与关键数值
- ADC鉴别肝血管瘤与肝转移瘤的AUC为0.940。
- D鉴别肝血管瘤与肝转移瘤的AUC为0.908。
- D*鉴别肝血管瘤与肝转移瘤的AUC为0.608。
- f鉴别肝血管瘤与肝转移瘤的AUC为0.686。
- DDC鉴别肝血管瘤与肝转移瘤的AUC为0.952。
临床应用与阅片要点
- ADC与DDC的AUC显著大于D*(P<0.0001)、f(P=0.0001)与α(P=0.0001),阅片时可优先参考ADC与DDC。
- 作者认为ADC与DDC可作为鉴别肝血管瘤与肝转移瘤的定量影像生物标志物。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: This study aims to compare the diagnostic values of mono-exponential, bi-exponential, and stretched exponential diffusion-weighted imaging (DWI) in differentiating hepatic hemangiomas and liver metastases.
METHOD: This prospective study was approved by our institutional review board, and written informed consent was obtained from all patients. In this study, 244 patients with known or suspected liver disease underwent magnetic resonance imaging. Among them, 37 patients who had focal hepatic lesions with a maximum diameter of ≥10 mm were evaluated. Using home-built software, two radiologists measured the DWI parameters of hepatic lesions for the three models: the apparent diffusion coefficient (ADC) from a mono-exponential model; the true diffusion coefficient (D), pseudo-diffusion coefficient (D*), and perfusion fraction (f) from a bi-exponential model; and the distributed diffusion coefficient (DDC) and water molecular diffusion heterogeneity index (α) from a stretched exponential model. The parameters were compared between hepatic hemangiomas and liver metastases.
RESULTS: In total, 64 focal hepatic lesions were evaluated, of which 22 were identified to be hepatic hemangiomas and 42 were liver metastases. ADC, D, f, and DDC values were significantly lower in liver metastases than in hepatic hemangiomas (P < 0.0001, < 0.0001, 0.015, and < 0.0001, respectively); whereas, the α value was significantly higher in liver metastases than in hepatic hemangiomas (P = 0.028). The areas under the ROC curve (AUCs) for differentiating hepatic hemangiomas and liver metastases in ADC, D, D*, f, DDC, and α were 0.940, 0.908, 0.608, 0.686, 0.952, and 0.667, respectively. The AUC values of ADC and DDC were significantly greater than those of D* (P < 0.0001), f (P = 0.0001), and α values (P = 0.0001).
CONCLUSION: ADC and DDC values from the mono-exponential and stretched exponential models could be considered as quantitative imaging biomarkers for differentiating hepatic hemangiomas and liver metastases.
引用
- Fujimoto K, Noda Y, Kawai N, et al. Comparison of mono-exponential, bi-exponential, and stretched exponential diffusion-weighted MR imaging models in differentiating hepatic hemangiomas from liver metastases. Eur J Radiol. 2021. PMID: 34120012. doi:10.1016/j.ejrad.2021.109806
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。